Eko-Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 5.70 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.66 Cr
as on 17-11-2024
- Company Age 37 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 81.45 Cr
as on 17-11-2024
- Satisfied Charges ₹ 110.05 Cr
as on 17-11-2024
- Revenue 6.74%
(FY 2023)
- Profit 30.42%
(FY 2023)
- Ebitda -2.55%
(FY 2023)
- Net Worth 8.35%
(FY 2023)
- Total Assets -3.27%
(FY 2023)
About Eko-Diagnostic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.70 Cr and a paid-up capital of Rs 1.66 Cr.
The company currently has active open charges totaling ₹81.45 Cr. The company has closed loans amounting to ₹110.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jeetendra Sharma, Nand Rathore, and Surendra Kumar serve as directors at the Company.
- CIN/LLPIN
U85120WB1987PTC043172
- Company No.
043172
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 1987
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- LocationCal-71., West Bengal
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Eko-Diagnostic?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jeetendra Sharma  | Director | 24-Sep-2003 | Current |
| Nand Rathore | Director | 20-Dec-1990 | Current |
| Surendra Kumar | Director | 16-Oct-1987 | Current |
Financial Performance of Eko-Diagnostic.
Eko-Diagnostic Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 6.74% increase. The company also saw a substantial improvement in profitability, with a 30.42% increase in profit. The company's net worth moved up by a moderate rise of 8.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eko-Diagnostic?
In 2023, Eko-Diagnostic had a promoter holding of 83.10% and a public holding of 16.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Calcutta Medical Imaging Institute LtdActive 35 years 3 months
Jeetendra Sharma, Nand Rathore and 1 more are mutual person
- Anusuya Sharma Medical Education FoundationActive 28 years 4 months
Nand Rathore and Surendra Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Feb 2022 | ₹1.30 Cr | Open |
Others Creation Date: 06 Oct 2020 | ₹5.99 M | Open |
Hdfc Bank Limited Creation Date: 25 Oct 2019 | ₹5.00 Cr | Open |
How Many Employees Work at Eko-Diagnostic?
Unlock and access historical data on people associated with Eko-Diagnostic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eko-Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eko-Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
